{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:06:24Z","timestamp":1790165184430,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00516869"],"award-info":[{"award-number":["RS-2025-00516869"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9A7050614"],"award-info":[{"award-number":["NRF-2017M3A9A7050614"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2021R1C1C2007117"],"award-info":[{"award-number":["NRF-2021R1C1C2007117"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prnil.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:38:24Z","timestamp":1780123104000},"page":"264-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma circulating tumor deoxyribonucleic acid methylation enables noninvasive disease stratification beyond prostate-specific antigen in prostate cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"Da-Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0416-4385","authenticated-orcid":false,"given":"Min-Hyeok","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungseok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Ho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Heon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mungchan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Kyu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Taek","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9672-2216","authenticated-orcid":false,"given":"Jae-Seung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2026.05.002_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/djaa154","article-title":"Recommended definitions of aggressive prostate cancer for etiologic epidemiologic research","volume":"113","author":"Hurwitz","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prnil.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.euo.2021.02.008","article-title":"A systematic review of prostate cancer heterogeneity: understanding the clonal ancestry of multifocal disease","volume":"4","author":"Erickson","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.prnil.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13402-016-0268-6","article-title":"PSA and beyond: alternative prostate cancer biomarkers","volume":"39","author":"Saini","year":"2016","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.prnil.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4111\/icu.20240229","article-title":"Prostate cancer theragnostics biomarkers: an update","volume":"65","author":"Kumar Am","year":"2024","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.prnil.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.prnil.2025.02.002","article-title":"Artificial intelligence-driven digital pathology in urological cancers: current trends and future directions","volume":"13","author":"Paik","year":"2025","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.prnil.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40291-014-0101-8","article-title":"Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential","volume":"18","author":"Galletti","year":"2014","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.prnil.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1373\/clinchem.2018.287102","article-title":"Circulating tumor cells in prostate cancer: from discovery to clinical utility","volume":"65","author":"Pantel","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.prnil.2026.05.002_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/cas.14745","article-title":"Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis","volume":"112","author":"Cho","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.prnil.2026.05.002_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10408363.2015.1023430","article-title":"Using circulating tumor cells to inform on prostate cancer biology and clinical utility","volume":"52","author":"Li","year":"2015","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.prnil.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s41467-024-45475-w","article-title":"Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer","volume":"15","author":"Fonseca","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.prnil.2026.05.002_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211049","article-title":"Circulating tumor DNA as a biomarker for precision medicine in prostate cancer: a systematic review","volume":"26","author":"Chanhih","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.prnil.2026.05.002_bib13","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1158\/1078-0432.CCR-24-1096","article-title":"Circulating tumor DNA assessment for treatment monitoring adds value to PSA in metastatic castration-resistant prostate cancer","volume":"30","author":"Sweeney","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prnil.2026.05.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102728","article-title":"Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer","volume":"54","author":"Kohli","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prnil.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.canlet.2011.12.026","article-title":"Epigenetic biomarkers in urological tumors: a systematic review","volume":"342","author":"Jer\u00f3nimo","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.prnil.2026.05.002_bib16","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/1878-0261.12978","article-title":"Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook","volume":"15","author":"Lianidou","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.prnil.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.prnil.2026.05.002_bib18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fgene.2019.01150","article-title":"DNA methylation cancer biomarkers: translation to the clinic","volume":"10","author":"Locke","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.prnil.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1200\/JCO.2004.07.151","article-title":"DNA methylation and cancer","volume":"22","author":"Das","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prnil.2026.05.002_bib20","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.1703577114","article-title":"DNA methylation markers for diagnosis and prognosis of common cancers","volume":"114","author":"Hao","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prnil.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.molmed.2020.12.011","article-title":"Liquid biopsy of methylation biomarkers in cell-free DNA","volume":"27","author":"Luo","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.prnil.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/ERC-15-0369","article-title":"Methylated circulating tumor DNA in blood: power in cancer prognosis and response","volume":"23","author":"Warton","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.prnil.2026.05.002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188588","article-title":"Machine learning in epigenomics: insights into cancer biology and medicine","volume":"1876","author":"Arslan","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.prnil.2026.05.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109302","article-title":"Artificial intelligence and deep learning algorithms for epigenetic sequence analysis: a review for epigeneticists and AI experts","volume":"183","author":"Tahir","year":"2024","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.prnil.2026.05.002_bib25","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1042\/BCJ20210084","article-title":"The roles of epigenetics in cancer progression and metastasis","volume":"478","author":"Chen","year":"2021","journal-title":"Biochem J"},{"key":"10.1016\/j.prnil.2026.05.002_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3892\/ijo.2022.5360","article-title":"Epigenetic modification regulates tumor progression and metastasis through EMT (Review)","volume":"60","author":"Tan","year":"2022","journal-title":"Int J Oncol"},{"key":"10.1016\/j.prnil.2026.05.002_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10555-023-10120-3","article-title":"Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics","volume":"42","author":"Janin","year":"2023","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.prnil.2026.05.002_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrc.2017.11","article-title":"Epigenetic and genetic heterogeneity in metastasis","volume":"17","author":"Alderton","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.prnil.2026.05.002_bib29","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1038\/s41388-025-03624-5","article-title":"From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies","volume":"44","author":"Pharo","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.prnil.2026.05.002_bib30","article-title":"Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges","volume":"5","author":"Li","year":"2024","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.prnil.2026.05.002_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s11912-025-01682-2","article-title":"The evolving role of PSMA-PET\/CT in prostate cancer management: an umbrella review of diagnostic restaging, therapeutic redirection, and survival impact","volume":"27","author":"Wang","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.prnil.2026.05.002_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3348\/kjr.2018.19.5.819","article-title":"Prostate-specific membrane antigen PET imaging in prostate cancer: opportunities and challenges","volume":"19","author":"Oh","year":"2018","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.prnil.2026.05.002_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.prnil.2020.09.001","article-title":"Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review","volume":"8","author":"Chung","year":"2020","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2026.05.002_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.prnil.2022.01.002","article-title":"Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer","volume":"10","author":"Cho","year":"2022","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2026.05.002_bib35","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1158\/1078-0432.CCR-23-3083","article-title":"Impact of circulating tumor cell-expressed prostate-specific membrane antigen and prostate-specific antigen transcripts in different stages of prostate cancer","volume":"30","author":"Cho","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prnil.2026.05.002_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10565-017-9418-5","article-title":"Progress and challenges of sequencing and analyzing circulating tumor cells","volume":"34","author":"Zhu","year":"2018","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.prnil.2026.05.002_bib37","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.18632\/oncotarget.26678","article-title":"Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development","volume":"10","author":"Li","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.prnil.2026.05.002_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00432-022-04421-3","article-title":"HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways","volume":"149","author":"Ding","year":"2023","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888226000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888226000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:47:19Z","timestamp":1790164039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888226000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2287888226000358"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2026.05.002","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma circulating tumor deoxyribonucleic acid methylation enables noninvasive disease stratification beyond prostate-specific antigen in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}